WaferGen Q3 Revenues Jump 54 Percent | GenomeWeb

NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Wednesday that its third quarter revenues rose 54 percent driven by increased SmartChip capital equipment sales.

For the three months ended Sept. 30, WaferGen reported total revenues of $2 million compared to $1.3 million in Q3 2014, in line with analysts' consensus estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.